Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4752 |  LGVN Longeveron Inc. - Class A Common stock | 2.37 USD | -2.87% | -7.42% | -63.65% | +315.79% | 7.56 M USD | ||
| 4755 |  CURX Curanex Pharmaceuticals Inc - Common Stock | 4.76 USD | -1.04% | +1.28% | +14.42% | +534.67% | 7.46 M USD | ||
| 4756 |  SKYE Skye Bioscience, Inc. - Common Stock | 1.68 USD | +1.82% | +2.44% | -23.64% | +110.00% | 7.44 M USD | ||
| 4759 |  FBLG FibroBiologics, Inc. - Common Stock | 1.11 USD | -2.63% | -7.50% | -35.84% | +126.53% | 7.39 M USD | ||
| 4760 |  TRAW Traws Pharma, Inc. - Common Stock | 0.48 USD | 0.00% | -14.29% | -11.11% | -84.42% | 7.38 M USD | ||
| 4765 |  INM InMed Pharmaceuticals Inc. - Common Shares | 1.33 USD | 0.00% | -2.92% | +1.53% | -43.40% | 7.31 M USD | ||
| 4766 |  APRE Aprea Therapeutics, Inc. - Common Stock | 0.56 USD | -8.20% | -22.22% | -28.21% | -62.67% | 7.05 M USD | ||
| 4767 |  BOLT Bolt Biotherapeutics, Inc. - Common Stock | 3.63 USD | +0.83% | +3.71% | -2.16% | -38.99% | 6.99 M USD | ||
| 4771 |  ENVB Enveric Biosciences, Inc. - Common Stock | 1.52 USD | +1.33% | +0.66% | +7.04% | -38.21% | 6.80 M USD | ||
| 4779 |  XCUR Exicure, Inc. - Common Stock | 1.01 USD | -0.98% | -13.68% | -28.37% | -82.59% | 6.61 M USD | ||
| 4780 |  ACXP Acurx Pharmaceuticals, Inc. - Common Stock | 1.25 USD | -3.85% | -2.34% | -11.35% | -34.90% | 6.59 M USD | ||
| 4782 |  ALZN Alzamend Neuro, Inc. - Common Stock | 1.34 USD | -2.19% | -0.74% | -19.76% | -41.99% | 6.47 M USD | ||
| 4794 |  NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 3.74 USD | -2.09% | -5.79% | +884.21% | +199.20% | 6.09 M USD | ||
| 4796 |  IMNN Imunon, Inc. - Common Stock | 1.07 USD | -4.46% | -20.74% | -35.54% | -67.08% | 6.00 M USD | ||
| 4803 |  KALA KALA BIO, Inc. - Common Stock | 0.30 USD | -16.67% | -26.83% | -46.43% | -80.52% | 5.80 M USD | ||
| 4808 |  CELZ Creative Medical Technology Holdings, Inc. - Common Stock | 0.86 USD | -2.27% | -6.52% | -18.10% | -75.29% | 5.67 M USD | ||
| 4812 |  PULM Pulmatrix, Inc. - Common Stock | 1.53 USD | +2.68% | -3.77% | +1.32% | -67.52% | 5.59 M USD | ||
| 4815 |  LEXX Lexaria Bioscience Corp. - Common Stock | 3.36 USD | -4.00% | +5.66% | -52.00% | +286.21% | 5.55 M USD | ||
| 4818 |  CDIO Cardio Diagnostics Holdings Inc. - Common stock | 1.86 USD | -5.58% | -5.58% | -7.92% | -29.01% | 5.50 M USD | ||
| 4820 |  AIM AIM ImmunoTech Inc. Common Stock | 0.18 USD | 0.00% | -5.26% | -18.18% | -93.21% | 5.48 M USD |
Notizie Biotechnology Stocks
Il farmaco di Pharvaris per l’HAE mostra un sollievo più rapido
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |